Dana Investment Advisors, Inc. Neogenomics Inc Transaction History
Dana Investment Advisors, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Dana Investment Advisors, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 23,600 shares of NEO stock, worth $229,392. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,600
Previous 23,600
-0.0%
Holding current value
$229,392
Previous $348,000
11.49%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$191 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$138 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$63.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$59.9 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$59.8 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.22B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...